IDEAYA Biosciences (IDYA) Equity Ratio (2018 - 2026)

IDEAYA Biosciences has disclosed Equity Ratio across 9 years of filings, most recently posting 0.91 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.91, down 2.24% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.91 (down 2.24% YoY), and the FY2025 annual result was 0.92, down 2.13% from the prior year.
• Equity Ratio came in at 0.91 for Q1 2026 at IDEAYA Biosciences, down from 0.92 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.97 in Q1 2024 to a low of 0.8 in Q2 2022.
• The 5-year median for Equity Ratio is 0.92 (2025), against an average of 0.92.
• Across the five-year window, Equity Ratio advanced 19.33% in 2023 and decreased 4.34% in 2025, its largest moves.
• IDEAYA Biosciences' Equity Ratio stood at 0.9 in 2022, then rose by 6.2% to 0.96 in 2023, then fell by 1.5% to 0.94 in 2024, then decreased by 2.13% to 0.92 in 2025, then retreated by 1.35% to 0.91 in 2026.
• The last three Equity Ratio figures came in at 0.91 (Q1 2026), 0.92 (Q4 2025), and 0.92 (Q3 2025), per Business Quant data.